Jennifer Crombie, Md
Clinical trials sponsored by Jennifer Crombie, Md, explained in plain language.
-
New hope for Tough-to-Treat lymphoma: experimental combo enters Mid-Stage trial
Disease control Recruiting nowThis study is testing whether adding two newer drugs, glofitamab and polatuzumab, to a standard chemotherapy regimen (R-CHP) works better for people with newly diagnosed, high-risk diffuse large B-cell lymphoma. About 40 participants will receive the drug combination for up to 8 …
Phase: PHASE2 • Sponsor: Jennifer Crombie, MD • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New Two-Pronged attack tested for Tough-to-Treat lymphoma
Disease control Recruiting nowThis study is testing whether combining two powerful cancer treatments—CAR-T cell therapy and the drug pembrolizumab—works better than either alone for a type of lymphoma that has returned or not responded to prior treatments. About 35 adults with relapsed or refractory primary m…
Phase: PHASE2 • Sponsor: Jennifer Crombie, MD • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC